Nabla Review Australia 2026: A Strong Scribe Built for Somewhere Else

Verdict (TL;DR): Nabla is one of the most polished ambient AI scribes on the market — fast, multi-specialty, and backed by serious money and serious deployments. But it was built for the United States and Europe. There is no Australian data-residency option: your patients' clinical notes sit on Google Cloud servers in the EU, processed through US-based speech-to-text. For an Australian GP weighing the Privacy Act, that is the whole decision. Until Nabla offers AU hosting and local clinical-software integration, Australian-built rivals are the safer pick.

Score: 14/25 — ⭐⭐⭐ Good

Australian Fit: 2/5 — no AU data residency, no AU clinical-software integrations, no published AU pricing or support hours.

Last reviewed: 7 June 2026 by Adam.

What Nabla is

Nabla Copilot is an ambient AI medical scribe. It listens to a consultation, then drafts a structured clinical note — history, symptoms, assessment, plan — in seconds. The clinician reviews, edits, and pushes the note into their record system. The pitch is simple: less typing, more time with patients.

The company is based in Paris, France, with a US office in Brooklyn, New York. It was founded by Alexandre Lebrun, Delphine Groll and Martin Raison; Lebrun previously ran Wit.ai (acquired by Facebook) and led engineering at Facebook's AI research lab. Nabla has raised roughly US$120 million since 2018, including a US$70 million Series C in June 2025 led by HV Capital.

This is not a hobby project. Nabla says it is deployed in 150-plus health organisations and used by 85,000-plus clinicians, including a large rollout across The Permanente Medical Group in the United States. The product covers 50-plus specialties and works in English and French.

The important word in all of that is "somewhere else." Every deployment of scale is American or European. Australia does not appear anywhere on Nabla's site, trust centre, or help centre.

What it costs in Australia

Here is the first problem. Nabla does not publish public pricing. There is no plan table, no list price, no per-seat figure on its site. The buying path is a sales call: the homepage offers "Talk to our team" and a free trial, nothing more. An Australian practice cannot see what it will pay without booking a meeting.

Some third-party aggregators report a free tier of around 30 notes per month, then roughly US$120 per provider per month. Nabla does not confirm those figures anywhere we could find, so we will not print them as fact. Treat them as unverified market chatter, not a quote you can rely on.

Because the only circulating price is unconfirmed, any AUD conversion would be a guess on top of a guess, so we are not publishing one. What we can state plainly is the tax position for an overseas supplier: Nabla is a non-resident digital-service provider, and under Australia's imported-services GST rules such suppliers must register and charge 10% GST once they pass the A$75,000 turnover threshold. That is the general rule for offshore software sold to Australian customers — not a vendor claim. Confirm GST handling in writing before you buy.

For an Australian practice, the absence of a public price is itself a red flag. Local rivals publish AUD pricing openly. Nabla makes you book a call. Australian clinicians should treat all pricing here as unconfirmed until Nabla quotes them in writing, in AUD, with GST stated.

How it works in practice

The workflow is the genuinely strong part. You open Nabla in a browser or mobile app, start a consultation, and it captures the conversation in the background. When the visit ends, it produces a structured note — typically a SOAP-style note — that you review and edit before it lands in your record system.

Nabla says a note is generated in under 20 seconds and claims clinicians save around 1.5 hours a day. Treat the time-saving as a vendor claim, not an independent finding.

On data handling, Nabla's design is better than most. Audio is not stored by default. Transcripts and notes are kept for 14 days by default, and that retention window is configurable. For a privacy-conscious clinician, "no audio retained" is a real point in its favour.

The catch is where that processing happens — which matters more in Australia than almost anywhere else. We cover that below.

What it does well

• Fast, clean notes. A structured clinical note in under 20 seconds is genuinely quick, and the output is well organised across 50-plus specialties.
• Strong compliance posture. SOC 2 Type 2, ISO 27001 (certified September 2025), HIPAA, GDPR and CCPA alignment, plus EU AI Act work. This is a mature security program.
• Audio not stored by default. Encounters are processed without keeping the recording, and notes default to a 14-day window.
• Deep US EHR integration. Epic, Oracle Health, Athenahealth, NextGen, Arya EHR and Greenway are all named integrations — excellent if you run those systems, which Australian general practice mostly does not.
• Serious backing and scale. US$120 million raised and 85,000-plus clinicians means this product will be maintained and improved.

What it doesn't do well

• No Australian data residency. Non-US clients' data is stored in EU Google Cloud data centres, with speech-to-text processed in US Azure regions. There is no AU hosting option. For Australian patient data, that is the headline failure.
• No published Australian pricing. Nabla publishes no public pricing at all — no list price, no AUD figure, no GST line. Buyers must book a sales call. You cannot compare it like-for-like off the shelf.
• No Australian clinical-software integrations. Nabla's named integrations are all US systems (Epic, Oracle Health, Athenahealth, NextGen, Arya EHR, Greenway). Its site lists no integration with Best Practice, MedicalDirector, Genie, or any other common Australian practice software.
• No stated Australian support hours. Nabla's site lists offices in Brooklyn and Paris and publishes no Australian support hours or local contact. Support and account management are US/EU-oriented; nothing addresses an Australian time zone.
• No Australian English or AU clinical context. The product lists English and French only. There is no signal it is tuned for AU terminology, MBS item context, or My Health Record.

Australian fit

This is where Nabla loses Australian clinicians, and it is worth being blunt.

Data residency. Nabla stores non-US clients' clinical data in EU Google Cloud data centres and runs speech-to-text through US Azure regions. There is no Australian hosting region. Australian health data is among the most sensitive personal information under the Privacy Act 1988, and many practices, hospitals, and state health services have policies — or strong preferences — for onshore storage. Nabla cannot meet an onshore requirement today.

Privacy Act posture. Nabla's compliance program is built around HIPAA (US), GDPR (EU), CCPA, PIPEDA (Canada) and the EU AI Act. There is no published mapping to the Australian Privacy Principles. A practice would need its own legal review and a privacy impact assessment before deploying — and would have to satisfy itself that cross-border disclosure to the US and EU meets APP 8.

Availability and support. Nabla does not market to Australia. We found no AU case studies, no AU pricing, and no stated AU support hours. The nearest regional reference we found was New Zealand practice guidance, which is not the same as an Australian deployment.

Clinical-software gaps. Australian general practice runs largely on Best Practice, MedicalDirector and Genie. Nabla integrates with US systems. Without an AU integration, notes likely move by copy-paste — workable, but not the the integrated workflow Nabla shows for Epic.

Pricing and GST. Nabla publishes no public price in any currency. As an offshore digital-service supplier it must charge 10% GST on Australian sales once over the A$75,000 threshold under the imported-services rules — but with no public billing detail, confirm this in writing before purchase.

The clinical caveat. As with any scribe: Nabla drafts, it does not decide. It does not replace clinical judgement. The treating clinician remains responsible for the accuracy and content of the medical record, and must review and correct every note before it is finalised. For Healthcare & Medical AI, this is not optional — it is the line that keeps the tool a tool.

Australian Fit score: 2/5.

Alternatives

If Australian fit is your priority — and for patient data, it should be — start with the locally built options:

• Heidi Health: Australian-founded ambient scribe with AU data residency and AU-aware workflows. Scores better on local fit.
• Lyrebird Health: Australian-built scribe with strong uptake in AU general practice and onshore data handling. Strong on local fit.
• Microsoft Dragon Copilot: Enterprise-grade scribe from a vendor with established Australian cloud regions — relevant for hospitals and larger groups that already run Microsoft.

The pattern is clear: Australian-built scribes win on the criterion that matters most here — local data residency and AU clinical fit. Nabla wins on raw product polish and funding. For most Australian practices, that trade does not favour Nabla.

Bottom line

Nabla is a very good scribe sold to the wrong continent. The product is fast, the compliance program is mature, and not storing audio by default is a genuine strength. If you practise in the US or EU on Epic or Athenahealth, it deserves a serious look.

For Australia, the answer is simpler. There is no onshore data option, no AU pricing, no AU clinical-software integration, and no AU support story. The defining question for an Australian clinician — where does my patients' data live? — has the wrong answer. Until Nabla offers Australian hosting, an Australian GP or specialist is better served by a local scribe built for the Privacy Act and AU practice software. Good tool. Wrong market. Not recommended for Australian clinicians today.

Score

Australian Fit gate: 2/5 — fails the Australian Fit gate. Australian Fit below 4/5 means Nabla cannot be rated Excellent or named a category Top Pick, regardless of raw score. See our Methodology.

Frequently asked questions

Is Nabla available in Australia?

There is no real Australian offering. Nabla does not market to Australia — no AU case studies, no AU pricing, and no stated AU support hours. The product is built and deployed for the United States and Europe.

Does Nabla charge in AUD?

No. Nabla publishes no public pricing at all — no list price, no AUD figure, no GST line. Buyers must book a sales call. As an offshore supplier it must charge 10% GST on Australian sales once over the A$75,000 threshold, but confirm this in writing before you buy.

Is there a free plan or free trial?

Nabla offers a free trial via its homepage. Some third-party aggregators report a free tier of around 30 notes a month, but Nabla does not confirm this, so treat it as unverified market chatter, not a quote.

Is patient data stored in Australia?

No — and this is the whole decision for an Australian clinician. Nabla stores non-US clients' clinical notes on EU Google Cloud servers and processes speech-to-text through US Azure regions. There is no Australian hosting option, which fails an onshore requirement under the Privacy Act 1988.

Does Nabla integrate with Australian clinical software?

No. Nabla's named integrations are all US systems (Epic, Oracle Health, Athenahealth and others). It lists no integration with Best Practice, MedicalDirector or Genie, so notes likely move by copy-paste. For local fit, Australian-built scribes are the safer pick.

Read next

• Category guide: Best AI Medical Scribes in Australia 2026

Sources

1. Nabla — homepage (product, founders' base, integrations, specialties, scale) — https://www.nabla.com/ — Wayback: https://web.archive.org/web/20260607022855/https://www.nabla.com/ — checked 7 June 2026
2. Nabla — Trust Center (certifications, data residency EU/US, retention defaults, encryption) — https://trust.nabla.com/ — Wayback: https://web.archive.org/web/20260411054726/https://trust.nabla.com/ — checked 7 June 2026
3. Nabla Help Centre — HIPAA / data compliance article (HIPAA, ISO 27001, 14-day retention, no audio by default) — https://help.nabla.com/ — Wayback: https://web.archive.org/web/20250908213529/https://help.nabla.com/ — checked 7 June 2026
4. Nabla — press release, personalised documentation (note speed, time-saving claim) — https://www.nabla.com/press-release/nabla-saves-clinicians-even-more-time-with-personalized-documentation — Wayback: https://web.archive.org/web/20251207215122/https://www.nabla.com/press-release/nabla-saves-clinicians-even-more-time-with-personalized-documentation — checked 7 June 2026
5. Sifted — "Paris-based AI startup Nabla raises $24m Series B" (founders, Paris base) [secondary, context] — https://sifted.eu/articles/nabla-24m-series-b — Wayback: https://web.archive.org/web/20260218213619/https://sifted.eu/articles/nabla-24m-series-b — checked 7 June 2026
6. Crunchbase News — "Nabla Lands $70M To Build AI Agents In Healthcare" (Series C, total funding) [secondary, context] — https://news.crunchbase.com/ai/nabla-ai-copilot-agents-healthcare-funding/ — Wayback: https://web.archive.org/web/20251216185844/https://news.crunchbase.com/ai/nabla-ai-copilot-agents-healthcare-funding/ — checked 7 June 2026
7. Fierce Healthcare — Nabla / Permanente Medical Group rollout (US deployment scale) [secondary, context] — https://www.fiercehealthcare.com/health-tech/medical-scribe-startup-nabla-rollout-tool-kaiser-permanente-docs — Wayback: https://web.archive.org/web/20260429053149/https://www.fiercehealthcare.com/health-tech/medical-scribe-startup-nabla-rollout-tool-kaiser-permanente-docs — checked 7 June 2026

The AI Directory Australia is an independent editorial publication. We don't accept payment for positive reviews. Read our Methodology and Affiliate Disclosure.